Identifies CaUGT enzyme modifying glycyrrhetinic acid, suggesting improved bioactivity through glycosylation.
Glycyrrhetinic acid (GA) is a major bioactive ingredient of licorice with extensive pharmacological functions, while its strong hydrophobicity and low permeability severely restrict practical application. Enzymatic glycosylation serves as a mild method to enhance GA solubility and bioactivity, yet few reported glycosyltransferases can specifically modify the C30 carboxyl group of GA. In this study, a novel glycosyltransferase gene CaUGT was identified and cloned from Cardamine amara subsp . amara . The recombinant GST-CaUGT achieved optimal expression under 2% dextrin, 0.2 mM IPTG and 25 °C induction temperature. The enzyme exhibited the highest activity at 25 °C and pH 6.0, with high thermal and pH stability. It displayed a strict regioselectivity toward the GA C30 carboxyl, with a K m of 0.0501 mmol/L and a k cat of 52.3 s –1 ·M –1 . A constructed two-enzyme cascade system produced 452.8 mg/L GA 30-O-glucoside with a space-time yield of 600.9 mg/L/h, providing an efficient biocatalytic route for triterpenoid carboxyl glycosylation.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: